Issue resolved with USFDA, says Dr Reddy's

Drug firm Dr Reddy’s Laboratories on Friday said it has resolved all issues raised by a division of US health regulator over its promotional material for an anti-coagulant injection. On January 10, Office of Prescription Drug Promotion had issued a letter to the company for changes related to certain promotional material for Fondaparinux Sodium for Injection. “The company has already addressed all matters raised by the Division of Professional Promotion, USFDA, in the letter issued on January 10,” the company said.